Year archive

Lepu Biopharma Co., Ltd. — 2025 filings

All 52 regulatory filings released by Lepu Biopharma Co., Ltd. (2157) in 2025, sourced directly from the official regulator.

52 Filings

2025 Period

2025 filings (52)

Filing	Released	Lang
UPDATES ON LICENSING TRANSACTION Capital/Financing Update	2025-12-18	English
POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 18, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-12-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
ARTICLES OF ASSOCIATION Governance Information	2025-12-02	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION Share Issue/Capital Change	2025-12-02	English
PROXY FORM FOR USE AT THE 2025 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-28	English
NOTICE OF THE SECOND 2025 EGM Proxy Solicitation & Information Statement	2025-11-28	English
(1) PROPOSED ADOPTION OF THE RESTRICTED SHARE UNIT SCHEME (H SHARE); AND (2) NOTICE OF THE SECOND 2025 EGM Proxy Solicitation & Information Statement	2025-11-28	English
CONTINUING CONNECTED TRANSACTION CDMO SERVICES FRAMEWORK AGREEMENT Regulatory Filings	2025-11-28	English
CONTINUING CONNECTED TRANSACTION NEW PROCUREMENT FRAMEWORK AGREEMENT Regulatory Filings	2025-11-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-05	English
RESIGNATION OF SUPERVISOR Board/Management Information	2025-10-31	English
INSIDE INFORMATION ANNOUNCEMENT MARKETING APPROVAL OBTAINED IN CHINA FOR MEIYOUHENG (BECOTATUG VEDOTIN INJECTION) Regulatory Filings	2025-10-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-20	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-06	English
POSITIVE PROFIT ALERT Earnings Release H1 2025	2025-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-06	English
LICENSING TRANSACTION Capital/Financing Update	2025-08-01	English
Next Day Disclosure Return Share Issue/Capital Change	2025-07-21	English
COMPLETION OF THE H SHARE FULL CIRCULATION Share Issue/Capital Change	2025-07-21	English
Next Day Disclosure Return Share Issue/Capital Change	2025-07-11	English
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-07-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-04	English
PLACING OF NEW H SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-07-04	English
NOMINATION COMMITTEE UNDER THE BOARD OF DIRECTORS TERMS OF REFERENCE Governance Information	2025-06-27	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-06-27	English
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE Board/Management Information	2025-06-27	English
POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON JUNE 27, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-27	English
INSIDE INFORMATION ANNOUNCEMENT GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE Share Issue/Capital Change	2025-06-19	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR Board/Management Information	2025-06-06	English
Proxy Form for the Annual General Meeting to be held on June 27 2025 Proxy Solicitation & Information Statement	2025-06-06	English
(1) 2024 REPORT OF THE BOARD OF DIRECTORS (2) 2024 REPORT OF THE BOARD OF SUPERVISORS (3) 2024 ANNUAL REPORT (4) 2024 FINANCIAL ACCOUNTS REPORT (5) 2025 FINANCIAL BUDGET (6) 2024 ANNUAL PROFIT DISTRIB Proxy Solicitation & Information Statement	2025-06-06	English
NOTICE OF THE 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-04	English
VOLUNTARY ANNOUNCEMENT THE PIVOTAL CLINICAL TRIAL RESULTS FOR MRG003 PRESENTED AS LBA AT 2025 ASCO ANNUAL MEETING Regulatory Filings	2025-06-01	English
INSIDE INFORMATION ANNOUNCEMENT ISSUANCE OF FILING NOTICE BY THE CSRC IN RESPECT OF THE COMPANY'S H SHARE FULL CIRCULATION APPLICATION Share Issue/Capital Change	2025-05-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-08	English
2024 Annual Report Annual Report FY 2024	2025-04-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-03	English
VOLUNTARY ANNOUNCEMENT MRG003 CLINICAL TRIAL RESULTS SELECTED AS LBA FOR ORAL PRESENTATION AT 2025 ASCO ANNUAL MEETING Regulatory Filings	2025-03-27	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-06	English
VOLUNTARY ANNOUNCEMENT UPDATE ON NEW DRUG APPLICATION OF MRG003 Regulatory Filings	2025-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
INSIDE INFORMATION ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT FOR NOVEL ADC MRG007 Regulatory Filings	2025-01-22	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2025-01-07	English
POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 7, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-01-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-07	English